Features Screener Stocks Charts
Sign In Sign Up

Dr Lal PathLabs Cash Flow Statement

NSE:LALPATHLAB | HEALTHCARE

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

1.16x

LALPATHLAB's operating cash flow exceeded net income in FY 2025, indicating earnings are backed by actual cash generation.

Free Cash Flow

₹5.25B

LALPATHLAB's free cash flow was ₹5.25B in FY 2025, up 8.3% from FY 2024.

Dividend Coverage

2.5x

LALPATHLAB's free cash flow covered dividends 2.5x in FY 2025, leaving room for reinvestment or debt reduction.

CapEx Intensity

7.8%

Capital expenditure was 7.8% of operating cash flow in FY 2025 for LALPATHLAB, indicating a capital-light business.

2-year LALPATHLAB cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 3.62B 4.92B
Cash flow Operating Activities 5.35B 5.69B
Investments in PPE -511.67M -442.94M
Cash flow Investing Activities -242.69M -3.03B
Dividend Paid -2.01B -2.07B
Cash flow Financing Activities -4.14B -3.34B
Cash at beginning of period 2.64B 3.61B
Cash at end of period 3.61B 2.93B
Free Cash Flow 4.84B 5.25B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025